BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Chang M, Lai M. A Quality Improvement Initiative Reduces 30-Day Rate of Readmission for Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2016;14:753-759. [PMID: 26407750 DOI: 10.1016/j.cgh.2015.08.041] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 11.7] [Reference Citation Analysis]
Number Citing Articles
1 Serigado JM, Barboza KC, Marcus P, Sigal SH. Clinical Impact of Depression in Cirrhosis. Curr Hepatology Rep 2018;17:22-32. [DOI: 10.1007/s11901-018-0386-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Tapper EB. Rifaximin for the prevention of readmissions for patients with hepatic encephalopathy - the price is right. Liver Int 2016;36:1252-4. [PMID: 27507251 DOI: 10.1111/liv.13130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Reynolds C, Esrailian E, Hommes D. Quality Improvement in Gastroenterology: A Systematic Review of Practical Interventions for Clinicians. Dig Dis Sci 2018;63:2507-18. [PMID: 30014225 DOI: 10.1007/s10620-018-5198-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Seraj SM, Campbell EJ, Argyropoulos SK, Wegermann K, Chung RT, Richter JM. Hospital readmissions in decompensated cirrhotics: Factors pointing toward a prevention strategy. World J Gastroenterol 2017; 23(37): 6868-6876 [PMID: 29085229 DOI: 10.3748/wjg.v23.i37.6868] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 16] [Article Influence: 5.2] [Reference Citation Analysis]
5 Samoylova ML, Covinsky KE, Haftek M, Kuo S, Roberts JP, Lai JC. Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study. Liver Transpl 2017;23:292-8. [PMID: 27884053 DOI: 10.1002/lt.24684] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
6 Tapper EB, Aberasturi D, Zhao Z, Hsu CY, Parikh ND. Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis. Aliment Pharmacol Ther 2020;51:1397-405. [PMID: 32363684 DOI: 10.1111/apt.15749] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
7 Ganapathy D, Acharya C, Lachar J, Patidar K, Sterling RK, White MB, Ignudo C, Bommidi S, DeSoto J, Thacker LR, Matherly S, Shaw J, Siddiqui MS, Puri P, Sanyal AJ, Luketic V, Lee H, Stravitz RT, Bajaj JS. The patient buddy app can potentially prevent hepatic encephalopathy-related readmissions. Liver Int. 2017;37:1843-1851. [PMID: 28618192 DOI: 10.1111/liv.13494] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
8 Neff G, Zachry W III. Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin. Pharmacoeconomics 2018;36:809-22. [PMID: 29651649 DOI: 10.1007/s40273-018-0641-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
9 Spiewak T, Taefi A, Patel S, Li CS, Chak E. Racial disparities of Black Americans hospitalized for decompensated liver cirrhosis. BMC Gastroenterol. 2020;20:245. [PMID: 32727386 DOI: 10.1186/s12876-020-01392-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Shaheen AA, Nguyen HH, Congly SE, Kaplan GG, Swain MG. Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States. Liver Int. 2019;39:878-884. [PMID: 30688401 DOI: 10.1111/liv.14054] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
11 Garg SK, Goyal H, Obaitan I, Shah PA, Sarvepalli S, Jophlin LL, Singh D, Asrani S, Kamath PS, Leise MD. Incidence and predictors of 30-day hospital readmissions for liver cirrhosis: insights from the United States National Readmissions Database. Ann Transl Med 2021;9:1052. [PMID: 34422964 DOI: 10.21037/atm-20-1762] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Lim N, Sanchez O, Olson A. Impact on 30-d readmissions for cirrhotic patients with ascites after an educational intervention: A pilot study. World J Hepatol 2019; 11(10): 701-709 [PMID: 31749900 DOI: 10.4254/wjh.v11.i10.701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Rush B, Deol N, Teriyaki A, Sey M, Jairath V, Walley KR, Celi LA, Brahmania M. Lower 90-day Hospital Readmission Rates for Esophageal Variceal Bleeding After TIPS: A Nationwide Linked Analysis. J Clin Gastroenterol 2020;54:90-5. [PMID: 30829905 DOI: 10.1097/MCG.0000000000001199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Strazzabosco M, Allen JI, Teisberg EO. Value-based care in hepatology: Strazzabosco, Allen, Teisberg. Hepatology 2017;65:1749-55. [DOI: 10.1002/hep.29042] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
15 Tapper EB. Early readmissions after liver transplantation and the power of quality improvement. Liver Transpl 2016;22:717-9. [PMID: 26939668 DOI: 10.1002/lt.24430] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Kandasamy C, Shah I, Yakah W, Ahmed A, Tintara S, Sorrento C, Freedman SD, Kothari DJ, Sheth SG. The Impact of an Inpatient Pancreatitis Service and Educational Intervention Program on the Outcome of Acute Pancreatitis. Am J Med 2021:S0002-9343(21)00700-2. [PMID: 34717902 DOI: 10.1016/j.amjmed.2021.09.021] [Reference Citation Analysis]
17 Thomson MJ, Lok AS, Tapper EB. Optimizing medication management for patients with cirrhosis: Evidence-based strategies and their outcomes. Liver Int 2018;38:1882-90. [PMID: 29845749 DOI: 10.1111/liv.13892] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
18 Sood KT, Wong RJ. Hepatic Encephalopathy is a Strong Predictor of Early Hospital Readmission Among Cirrhosis Patients. J Clin Exp Hepatol 2019;9:484-90. [PMID: 31571775 DOI: 10.1016/j.jceh.2019.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Orman ES, Ghabril M, Emmett TW, Chalasani N. Hospital Readmissions in Patients with Cirrhosis: A Systematic Review. J Hosp Med. 2018;. [PMID: 29694458 DOI: 10.12788/jhm.2967] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
20 Acharya C, Sehrawat TS, McGuire DB, Shaw J, Fagan A, McGeorge S, Olofson A, White MB, Gavis E, Kamath PS, Bergstrom L, Bajaj JS. Perspectives of Inpatients With Cirrhosis and Caregivers on Using Health Information Technology: Cross-sectional Multicenter Study. J Med Internet Res 2021;23:e24639. [PMID: 33744844 DOI: 10.2196/24639] [Reference Citation Analysis]
21 Siddique SM, Lane-Fall M, McConnell MJ, Jakhete N, Crismale J, Porges S, Khungar V, Mehta SJ, Goldberg D, Li Z, Schiano T, Regan L, Orloski C, Shea JA. Exploring opportunities to prevent cirrhosis admissions in the emergency department: A multicenter multidisciplinary survey. Hepatol Commun 2018;2:237-44. [PMID: 29507899 DOI: 10.1002/hep4.1141] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
22 Orr JG, Currie CJ, Berni E, Goel A, Moriarty KJ, Sinha A, Gordon F, Dethier A, Dillon JF, Clark K, Richardson P, Middleton P, Patel V, Shawcross D, Preedy H, Aspinall RJ, Hudson M. The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-α. Liver Int 2016;36:1295-303. [PMID: 26950766 DOI: 10.1111/liv.13111] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
23 Aspinall RJ. Reducing recurrent hospital admissions in patients with decompensated cirrhosis. Br J Hosp Med (Lond) 2018;79:93-6. [PMID: 29431486 DOI: 10.12968/hmed.2018.79.2.93] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Peery AF, Crockett SD, Murphy CC, Jensen ET, Kim HP, Egberg MD, Lund JL, Moon AM, Pate V, Barnes EL, Schlusser CL, Baron TH, Shaheen NJ, Sandler RS. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021. Gastroenterology 2021:S0016-5085(21)03655-6. [PMID: 34678215 DOI: 10.1053/j.gastro.2021.10.017] [Reference Citation Analysis]
25 Bloom PP, Marx M, Wang TJ, Green B, Ha J, Bay C, Chung RT, Richter JM. Attitudes towards digital health tools for outpatient cirrhosis management in patients with decompensated cirrhosis. BMJ Innov 2020;6:18-25. [DOI: 10.1136/bmjinnov-2019-000369] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
26 Tapper EB, Halbert B, Mellinger J. Rates of and Reasons for Hospital Readmissions in Patients With Cirrhosis: A Multistate Population-based Cohort Study. Clin Gastroenterol Hepatol. 2016;14:1181-1188.e2. [PMID: 27085758 DOI: 10.1016/j.cgh.2016.04.009] [Cited by in Crossref: 105] [Cited by in F6Publishing: 97] [Article Influence: 17.5] [Reference Citation Analysis]
27 Tapper EB. A Trial of Ornithine Phenylacetate and the Arc of Ammonia's History in the Management of Overt Hepatic Encephalopathy. Clin Gastroenterol Hepatol 2021;19:2493-5. [PMID: 33157316 DOI: 10.1016/j.cgh.2020.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Morales BP, Planas R, Bartoli R, Morillas RM, Sala M, Casas I, Armengol C, Masnou H. HEPACONTROL. A program that reduces early readmissions, mortality at 60 days, and healthcare costs in decompensated cirrhosis. Dig Liver Dis. 2018;50:76-83. [PMID: 28870446 DOI: 10.1016/j.dld.2017.08.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
29 Luo M, Mu R, Liu JF, Bai FH. Novel computerized psychometric tests as primary screening tools for the diagnosis of minimal hepatic encephalopathy. World J Clin Cases 2020; 8(16): 3377-3389 [PMID: 32913845 DOI: 10.12998/wjcc.v8.i16.3377] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Salman T, Elsabaawy M, Omar M, Afify M, Elezawy H, Ghanem S, Abdelraouf O, Rewisha E, Shebl N. Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study. Clin Exp Hepatol 2021;7:312-9. [PMID: 34712834 DOI: 10.5114/ceh.2021.109292] [Reference Citation Analysis]
31 Potnis A, VanMeter S, Stange J. Prevalence of Hepatic Encephalopathy from a Commercial Medical Claims Database in the United States. Int J Hepatol 2021;2021:8542179. [PMID: 34211786 DOI: 10.1155/2021/8542179] [Reference Citation Analysis]
32 Tapper EB, Parikh ND, Sengupta N, Mellinger J, Ratz D, Lok AS, Su GL. A risk score to predict the development of hepatic encephalopathy in a population‐based cohort of patients with cirrhosis. Hepatology 2018;68:1498-507. [DOI: 10.1002/hep.29628] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 8.5] [Reference Citation Analysis]
33 Mazer LM, Méan M, Tapper EB. Who Orders a Head CT?: Perceptions of the Cirrhotic Bleeding Risk in an International, Multispecialty Survey Study. Journal of Clinical Gastroenterology 2017;51:632-8. [DOI: 10.1097/mcg.0000000000000775] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
34 Wasfy JH, Hidrue MK, Ngo J, Tanguturi VK, Cafiero-Fonseca ET, Thompson RW, Johnson N, McDermott ST, Singh JP, Del Carmen MG, Ferris TG. Association of an Acute Myocardial Infarction Readmission-Reduction Program With Mortality and Readmission. Circ Cardiovasc Qual Outcomes 2020;13:e006043. [PMID: 32393130 DOI: 10.1161/CIRCOUTCOMES.119.006043] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
35 Trivedi PJ. Editorial: liver disease in secondary care-'money or your life'. Aliment Pharmacol Ther 2021;54:854-5. [PMID: 34425004 DOI: 10.1111/apt.16540] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Rosenblatt R, Cohen-mekelburg S, Shen N, Tafesh Z, Lucero C, Kumar S, Fortune B, Liu SY, Brown R, Jesudian A. Cirrhosis as a Comorbidity in Conditions Subject to the Hospital Readmissions Reduction Program. Am J Gastroenterol 2019;114:1488-95. [DOI: 10.14309/ajg.0000000000000257] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
37 Qazi Arisar FA, Abid S, Shaikh PA, Awan S. Impact of sepsis and non-communicable diseases on prognostic models to predict the outcome of hospitalized chronic liver disease patients. World J Hepatol 2018; 10(12): 944-955 [PMID: 30631399 DOI: 10.4254/wjh.v10.i12.944] [Reference Citation Analysis]
38 Kim TH, Park EC, Jang SI, Jang SY, Lee SA, Choi JW. Effects of diagnosis-related group payment system on appendectomy outcomes. J Surg Res 2016;206:347-54. [PMID: 27884328 DOI: 10.1016/j.jss.2016.08.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
39 Rose CF, Amodio P, Bajaj JS, Dhiman RK, Montagnese S, Taylor-Robinson SD, Vilstrup H, Jalan R. Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. J Hepatol. 2020;73:1526-1547. [PMID: 33097308 DOI: 10.1016/j.jhep.2020.07.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
40 Elsaid MI, John T, Li Y, Pentakota SR, Rustgi VK. The Health Care Burden of Hepatic Encephalopathy. Clinics in Liver Disease 2020;24:263-75. [DOI: 10.1016/j.cld.2020.01.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
41 Tanguturi VK, Temin E, Yeh RW, Thompson RW, Rao SK, Mallick A, Cavallo E, Ferris TG, Wasfy JH. Clinical Interventions to Reduce Preventable Hospital Readmission After Percutaneous Coronary Intervention. Circ: Cardiovascular Quality and Outcomes 2016;9:600-4. [DOI: 10.1161/circoutcomes.116.003086] [Cited by in Crossref: 30] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
42 Moghe A, Yakovchenko V, Morgan T, McCurdy H, Scott D, Rozenberg-Ben-Dror K, Rogal S. Strategies to Improve Delivery of Cirrhosis Care. Curr Treat Options Gastroenterol 2021;:1-11. [PMID: 34054289 DOI: 10.1007/s11938-021-00345-y] [Reference Citation Analysis]
43 Tapper EB, Hao S, Lin M, Mafi JN, McCurdy H, Parikh ND, Lok AS. The Quality and Outcomes of Care Provided to Patients with Cirrhosis by Advanced Practice Providers. Hepatology 2020;71:225-34. [PMID: 31063262 DOI: 10.1002/hep.30695] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
44 Patidar KR, Thacker LR, Wade JB, White MB, Gavis EA, Fagan A, Sterling RK, Fuchs M, Siddiqui MS, Matherly S, Stravitz RT, Sanyal AJ, Puri P, Luketic VA, Bajaj JS. Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis. Dig Dis Sci 2017;62:1173-9. [PMID: 28258378 DOI: 10.1007/s10620-017-4509-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
45 Ho SB, Matheny ME, Schnabl BE. Changes in Hospital Admissions and Mortality for Complications of Cirrhosis: Implications for Clinicians and Health Systems. Gut Liver 2016;10:8-9. [PMID: 26696026 DOI: 10.5009/gnl15593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
46 Kruger AJ, Durkin C, Mumtaz K, Hinton A, Krishna SG. Early Readmission Predicts Increased Mortality in Cirrhosis Patients After Clostridium difficile Infection. J Clin Gastroenterol 2019;53:e322-7. [PMID: 30045168 DOI: 10.1097/MCG.0000000000001090] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
47 Williams R, Aithal G, Alexander GJ, Allison M, Armstrong I, Aspinall R, Baker A, Batterham R, Brown K, Burton R, Cramp ME, Day N, Dhawan A, Drummond C, Ferguson J, Foster G, Gilmore I, Greenberg J, Henn C, Jarvis H, Kelly D, Mathews M, Mccloud A, Macgilchrist A, Mckee M, Moriarty K, Morling J, Newsome P, Rice P, Roberts S, Rutter H, Samyn M, Severi K, Sheron N, Thorburn D, Verne J, Vohra J, Williams J, Yeoman A. Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK. The Lancet 2020;395:226-39. [DOI: 10.1016/s0140-6736(19)32908-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 8.5] [Reference Citation Analysis]
48 Brahmania M, Wiskar K, Walley KR, Celi LA, Rush B. Lower household income is associated with an increased risk of hospital readmission in patients with decompensated cirrhosis. J Gastroenterol Hepatol 2021;36:1088-94. [PMID: 32562577 DOI: 10.1111/jgh.15153] [Reference Citation Analysis]
49 Rao BB, Sobotka A, Lopez R, Romero-Marrero C, Carey W. Outpatient telephonic transitional care after hospital discharge improves survival in cirrhotic patients. World J Hepatol 2019; 11(8): 646-655 [PMID: 31528247 DOI: 10.4254/wjh.v11.i8.646] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
50 Qu Y, Li T, Lin C, Liu F, Wu S, Wang L, Ye Q. Animal naming test for the assessment of minimal hepatic encephalopathy in Asian cirrhotic populations. Clin Res Hepatol Gastroenterol 2021;45:101729. [PMID: 34091081 DOI: 10.1016/j.clinre.2021.101729] [Reference Citation Analysis]
51 Kwok CS, Capers Q 4th, Savage M, Gulati M, Potts J, Mohamed MO, Nagaraja V, Patwala A, Heatlie G, Kontopantelis E, Fischman DL, Mamas MA. Unplanned hospital readmissions after acute myocardial infarction: a nationwide analysis of rates, trends, predictors and causes in the United States between 2010 and 2014. Coron Artery Dis 2020;31:354-64. [PMID: 31972608 DOI: 10.1097/MCA.0000000000000844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
52 Tapper EB, Friderici J, Borman ZA, Alexander J, Bonder A, Nuruzzaman N, Ramdass S, Ghaoui R. A Multicenter Evaluation of Adherence to 4 Major Elements of the Baveno Guidelines and Outcomes for Patients With Acute Variceal Hemorrhage. Journal of Clinical Gastroenterology 2018;52:172-7. [DOI: 10.1097/mcg.0000000000000820] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
53 Bajaj JS, O'Leary JG, Tandon P, Wong F, Garcia-Tsao G, Kamath PS, Maliakkal B, Biggins SW, Thuluvath PJ, Fallon MB, Subramanian RM, Vargas HE, Lai J, Thacker LR, Reddy KR. Hepatic Encephalopathy Is Associated With Mortality in Patients With Cirrhosis Independent of Other Extrahepatic Organ Failures. Clin Gastroenterol Hepatol 2017; 15: 565-574. e4. [PMID: 27720916 DOI: 10.1016/j.cgh.2016.09.157] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 10.0] [Reference Citation Analysis]
54 Kruger AJ, Aberra F, Black SM, Hinton A, Hanje J, Conteh LF, Michaels AJ, Krishna SG, Mumtaz K. A validated risk model for prediction of early readmission in patients with hepatic encephalopathy. Annals of Hepatology 2019;18:310-7. [DOI: 10.1016/j.aohep.2018.08.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
55 Tapper EB, Parikh ND. The Future of Quality Improvement for Cirrhosis. Liver Transpl 2021. [PMID: 33887806 DOI: 10.1002/lt.26079] [Reference Citation Analysis]
56 Choi JW, Kim SJ, Park HK, Jang SI, Kim TH, Park EC. Effects of a mandatory DRG payment system in South Korea: Analysis of multi-year nationwide hospital claims data. BMC Health Serv Res 2019;19:776. [PMID: 31666066 DOI: 10.1186/s12913-019-4650-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
57 Serper M, Kaplan DE, Lin M, Taddei TH, Parikh ND, Werner RM, Tapper EB. Inpatient Gastroenterology Consultation and Outcomes of Cirrhosis-Related Hospitalizations in Two Large National Cohorts. Dig Dis Sci 2021. [PMID: 34374917 DOI: 10.1007/s10620-021-07150-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Bittermann T, Hubbard RA, Serper M, Lewis JD, Hohmann SF, VanWagner LB, Goldberg DS. Healthcare utilization after liver transplantation is highly variable among both centers and recipients. Am J Transplant 2018;18:1197-205. [PMID: 29024364 DOI: 10.1111/ajt.14539] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
59 Karlsen TH, Sheron N, Zelber-Sagi S, Carrieri P, Dusheiko G, Bugianesi E, Pryke R, Hutchinson SJ, Sangro B, Martin NK, Cecchini M, Dirac MA, Belloni A, Serra-Burriel M, Ponsioen CY, Sheena B, Lerouge A, Devaux M, Scott N, Hellard M, Verkade HJ, Sturm E, Marchesini G, Yki-Järvinen H, Byrne CD, Targher G, Tur-Sinai A, Barrett D, Ninburg M, Reic T, Taylor A, Rhodes T, Treloar C, Petersen C, Schramm C, Flisiak R, Simonova MY, Pares A, Johnson P, Cucchetti A, Graupera I, Lionis C, Pose E, Fabrellas N, Ma AT, Mendive JM, Mazzaferro V, Rutter H, Cortez-Pinto H, Kelly D, Burton R, Lazarus JV, Ginès P, Buti M, Newsome PN, Burra P, Manns MP. The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet 2022;399:61-116. [PMID: 34863359 DOI: 10.1016/S0140-6736(21)01701-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Koola JD, Ho SB, Cao A, Chen G, Perkins AM, Davis SE, Matheny ME. Predicting 30-Day Hospital Readmission Risk in a National Cohort of Patients with Cirrhosis. Dig Dis Sci 2020;65:1003-31. [PMID: 31531817 DOI: 10.1007/s10620-019-05826-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
61 Hirode G, Saab S, Wong RJ. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults. JAMA Netw Open 2020;3:e201997. [PMID: 32239220 DOI: 10.1001/jamanetworkopen.2020.1997] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
62 Bajaj JS, O'Leary JG, Tandon P, Wong F, Kamath PS, Biggins SW, Garcia-Tsao G, Lai J, Fallon MB, Thuluvath PJ, Vargas HE, Maliakkal B, Subramanian RM, Thacker LR, Reddy KR. Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi-centre cohort. Aliment Pharmacol Ther 2019;49:1518-27. [PMID: 31032966 DOI: 10.1111/apt.15265] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
63 Piano S, Morando F, Carretta G, Tonon M, Vettore E, Rosi S, Stanco M, Pilutti C, Romano A, Brocca A, Sticca A, Donato D, Angeli P. Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections. Am J Gastroenterol 2017;112:1575-83. [PMID: 28853729 DOI: 10.1038/ajg.2017.253] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
64 Wigg AJ, Chin JK, Muller KR, Ramachandran J, Woodman RJ, Kaambwa B. Cost-effectiveness of a chronic disease management model for cirrhosis: Analysis of a randomized controlled trial. J Gastroenterol Hepatol. 2018;:. [PMID: 29462834 DOI: 10.1111/jgh.14127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Tey KR, Mohan P, Liu X, Desai AP. Closing the Quality Chasm in Cirrhosis. Clin Liver Dis (Hoboken) 2018;12:45-9. [PMID: 30988910 DOI: 10.1002/cld.725] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
66 Hirode G, Vittinghoff E, Wong RJ. Increasing Burden of Hepatic Encephalopathy Among Hospitalized Adults: An Analysis of the 2010-2014 National Inpatient Sample. Dig Dis Sci 2019;64:1448-57. [PMID: 30863953 DOI: 10.1007/s10620-019-05576-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
67 Tapper EB, Parikh ND, Waljee AK, Volk M, Carlozzi NE, Lok AS. Diagnosis of Minimal Hepatic Encephalopathy: A Systematic Review of Point-of-Care Diagnostic Tests. Am J Gastroenterol 2018;113:529-38. [PMID: 29533396 DOI: 10.1038/ajg.2018.6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
68 Tapper EB. Challenge accepted: Confronting readmissions for our patients with cirrhosis. Hepatology. 2016;64:26-28. [PMID: 26806609 DOI: 10.1002/hep.28471] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
69 Mathur AK, Talwalkar J. Quality measurement and improvement in liver transplantation. J Hepatol. 2018;68:1300-1310. [PMID: 29559346 DOI: 10.1016/j.jhep.2018.02.034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
70 Gonzalez JJ, DiBattista J, Gomez V, Gonzalez E, Zhang Q, Vaughn VM, Tapper EB. Impact of Inpatient Attending Specialty and Gastroenterology Consultation on Quality of Care of Patients Hospitalized with Decompensated Cirrhosis. Am J Med 2021:S0002-9343(21)00366-1. [PMID: 34144013 DOI: 10.1016/j.amjmed.2021.05.010] [Reference Citation Analysis]
71 Sarwar A, Weinstein JL, Novack V, Chakrala N, Tapper EB, Malik R, Ahmed M. Causes and Rates of 30-Day Readmissions After Transjugular Intrahepatic Portosystemic Shunts. AJR Am J Roentgenol 2020;215:235-41. [PMID: 32374665 DOI: 10.2214/AJR.19.21732] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Carbonneau M, Eboreime EA, Hyde A, Campbell-scherer D, Faris P, Gramlich L, Tsuyuki RT, Congly SE, Shaheen AA, Sadler M, Zeman M, Spiers J, Abraldes JG, Sugars B, Sia W, Green L, Abdellatif D, Schaefer JP, Selvarajah V, Marr K, Ryan D, Westra Y, Bakshi N, Varghese JC, Tandon P. The cirrhosis care Alberta (CCAB) protocol: implementing an evidence-based best practice order set for the management of liver cirrhosis - a hybrid type I effectiveness-implementation trial. BMC Health Serv Res 2020;20. [DOI: 10.1186/s12913-020-05427-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Volk ML, Kanwal F. Quality of Care in the Cirrhotic Patient. Clin Transl Gastroenterol 2016;7:e166. [PMID: 27101005 DOI: 10.1038/ctg.2016.25] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
74 Reuter B, Shaw J, Hanson J, Tate V, Acharya C, Bajaj JS. Nutritional Assessment in Inpatients with Cirrhosis can be Improved after Training and is Associated with Lower Readmissions. Liver Transpl. 2019;. [PMID: 31301208 DOI: 10.1002/lt.25602] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
75 Tapper EB. Building Effective Quality Improvement Programs for Liver Disease: A Systematic Review of Quality Improvement Initiatives. Clin Gastroenterol Hepatol 2016;14:1256-1265.e3. [PMID: 27103114 DOI: 10.1016/j.cgh.2016.04.020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]